1. Home
  2. NSPR vs VIVO Comparison

NSPR vs VIVO Comparison

Compare NSPR & VIVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.72

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

Logo VivoPower PLC Ordinary Shares

VIVO

VivoPower PLC Ordinary Shares

N/A

Current Price

$5.47

Market Cap

80.1M

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
NSPR
VIVO
Founded
2005
2014
Country
United States
United Kingdom
Employees
N/A
41
Industry
Medical/Dental Instruments
Power Generation
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
80.1M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
NSPR
VIVO
Price
$0.72
$5.47
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
157.0K
2.0M
Earning Date
05-04-2026
05-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,310,000.00
N/A
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$1.97
52 Week High
$2.93
$6.86

Technical Indicators

Market Signals
Indicator
NSPR
VIVO
Relative Strength Index (RSI) 28.77 57.18
Support Level N/A $4.24
Resistance Level $1.04 $6.86
Average True Range (ATR) 0.09 0.79
MACD -0.00 -0.05
Stochastic Oscillator 5.72 44.92

Price Performance

Historical Comparison
NSPR
VIVO

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About VIVO VivoPower PLC Ordinary Shares

VivoPower PLC is engaged in building, owning, and leasing powered land and data center infrastructure for AI compute applications. The group delivers specialized infrastructure solutions across the AI Data Centers, Power-to-X, and Electric Mobility. It is develop and operated infrastructure that enables sovereign nations and institutional partners to secure control over power, data, and national intelligence, supporting AI, compute-intensive workloads, and energy transition use cases.

Share on Social Networks: